Evidence map›Paper›PMID 36439390›Full record

ArticleClinical case reports2022

Delayed diagnosis of intraplacental choriocarcinoma in a term healthy neonate-A case report and literature review.

Mahdokht Azizi, Mojgan Akbarzade-Jahromi, Parvin Ghaffari, Mazaher Ramezani

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Repurposing metformin for choriocarcinoma: targeting the AMPK/mTOR pathway.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mahdokht AziziDepartment of Pathology Shahid beheshti hospital, Yasuj University of Medical sciences Yasuj Iran.
Mojgan Akbarzade-JahromiMaternal-fetal medicine Research Center, Department of Pathology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Parvin GhaffariDepartment of Obstetrics and Gynecology Yasuj University of Medical Sciences Yasuj Iran.
Mazaher RamezaniClinical Research Development Center Imam Reza Hospital, Kermanshah University of Medical Sciences Kermanshah Iran.ORCID https://orcid.org/0000-0003-1897-7410
Yasuj University of Medical Sciences · IRKermanshah University of Medical Sciences · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational choriocarcinoma is rare. The intraplacental formation of choriocarcinoma is much rarer. We present a diagnosis of choriocarcinoma, 4 months postpartum, in a 28-year-old, presenting with vaginal bleeding. Three weeks after the last chemotherapy session, the patient's β-HCG titer was normal and did not require hysterectomy.

Indexed as

case reportschoriocarcinomaplacenta diseasesrare diseasesterm pregnancy

Identifiers

PMID36439390
PMCPMC9684689
OpenAlexW4309929538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.